<DOC>
	<DOCNO>NCT01713504</DOCNO>
	<brief_summary>The purpose characterize new hypereosinophilic syndrome biomarkers informative accessible compare already thanks proteomic approach . This help investigator diagnose disease .</brief_summary>
	<brief_title>Identification New Markers Hypereosinophilic Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Hypereosinophilic Syndrome</mesh_term>
	<criteria>date sign informed consent virale serology negative negative result le 6 month virale serology negative HBV vaccinate patient insured virale serology negative negative result le 6 month negative pregnancy test female menopause least 1 year subject enable adult , guardianship protective measure justice Refusal inability give inform consent The hypereosinophilic syndrome explain origin atopy , bullous pemphigoid , ChurgStrauss syndrome DRESS</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>